Phenomix Report issue

For profit Phase 3
Founded: San Diego CA United States (2001)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2006
NCT00530881
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Phenomix Corp.

Active Ingredients

Drugs in Phase 3 Trials (2)

dutogliptin (11 trials)

sitagliptin (januvia) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Renal Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 2